Formulation comprising thymol useful in the treatment of drug resistant bacterial infections

US6514541B2 · kind B2 · utility

Assignee

• COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH · IN

Inventors

• Suman Preet Singh Khanuja · Lucknow, IN
• Suchi Srivastava · New Delhi, IN
• Ajit Kumar Shasney · Lucknow, IN
• Mahendra Pandurang Darokar · Lucknow, IN
• Tiruppadiripuliyur Ranganathan Santha Kumar · Lucknow, IN
• Krishna Kumar Agarwal · Lucknow, IN
• Ateeque Ahmed · Lucknow, IN
• Nirmal Kumar Patra · Lucknow, IN
• Prachi Sinha · Lucknow, IN
• Sunita Dhawan · Lucknow, IN
• Dharmendra Saikia · Lucknow, IN
• Sushil Kumar · Lucknow, IN

Key dates

• Filing date: Mar 28, 2000
• Grant date: Feb 4, 2003
• Expiry date: Mar 28, 2020

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K36/534
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A formulation useful in the treatment of drug resistant bacterial infections comprising an effective amount of thymol obtained from the plant Trachyspermum ammi, mint oil containing an appropriate amount of monoterpenes obtained from a hybrid of Mentha spicata and Mentha arvensis, and conventional additives. A method for producing the formulation by mixing the above ingredients and a method for the treatment of drug resistance in a patient by administration of a therapeutically effective amount of the formulation.